Vps4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
VPS4 (Vacuolar Protein Sorting 4 Homolog) is an AAA+ ATPase that functions in the final stages of multivesicular body (MVB) sorting and autophagy. It is essential for the disassembly of the ESCRT-III complex and the recycling of ESCRT components from endosomal membranes. VPS4 dysfunction contributes to neurodegenerative diseases including Alzheimer's and ALS.
VPS4 is a ~437 amino acid AAA+ ATPase:
- N-terminal MIT (Microtubule Interacting and Trafficking) domain: Binds to ESCRT-III proteins
- AAA+ ATPase domain: Hexameric ring that hydrolyzes ATP for disassembly
- C-terminal region: Contains autoinhibitory domain
- VPS4A: Ubiquitously expressed isoform
- VPS4B: Predominantly expressed in neuronal tissues
VPS4 is the final executor of membrane remodeling:
- ESCRT-III disassembly: Uses ATP hydrolysis to disassemble ESCRT-III polymers
- MVB sorting: Essential for sorting ubiquitinated cargo into intralumenal vesicles
- Autophagosome closure: Involved in autophagosome closure and lysosomal fusion
- Cytokinetic abscission: Required for membrane fission during cytokinesis
- Viral budding: Facilitates budding of enveloped viruses
- ATP binding induces conformational change
- MIT domain binds ESCRT-III
- ATP hydrolysis provides energy for disassembly
- ADP release resets the enzyme
- VPS4 dysfunction impairs MVB sorting of amyloid precursor protein (APP)
- Contributes to amyloid-β generation and secretion
- Reduced VPS4 in AD brains
- VPS4A mutations identified in ALS cases
- Impaired endolysosomal trafficking
- Contributes to TDP-43 proteinopathy
- VPS4 involved in mitophagy
- Impaired autophagic clearance of damaged mitochondria
- Lysosomal dysfunction in PD models
| Approach |
Status |
Description |
| VPS4 activators |
Research |
Small molecules to enhance VPS4 ATPase activity |
| ESCRT modulators |
Preclinical |
Target ESCRT-III-VPS4 interaction |
| Gene therapy |
Research |
VPS4 overexpression for neuroprotection |
- VPS4 in ESCRT function - Hanson PI et al., Nat Rev Mol Cell Biol 2009
- VPS4 in neurodegeneration - Urwin H et al., Nat Rev Neurol 2018
- VPS4 and autophagy - Lindhout FW et al., Autophagy 2021
¶ VPS4 and Neurodegeneration
VPS4 dysfunction in neurodegenerative diseases involves:
- Impaired ESCRT-III disassembly leading to endosomal trafficking defects
- Accumulation of aberrant multivesicular bodies
- Dysregulated autophagosome-lysosome fusion
- Defective cargo sorting in the endolysosomal pathway
- VPS4A expression reduced in AD prefrontal cortex
- Contributes to APP processing abnormalities
- Impaired clearance of amyloid-β through endosomal pathways
- Correlates with tau pathology severity
- VPS4A mutations identified in familial ALS cases
- Dysregulated endolysosomal trafficking contributes to TDP-43 mislocalization
- Impaired autophagic clearance of ubiquitinated proteins
- VPS4 activity modulators in development
- Gene therapy approaches to restore VPS4 function
- Combination therapies targeting ESCRT pathway
Current research focuses on:
- Developing VPS4-specific activators
- Understanding isoform-specific functions in neurons
- Identifying biomarkers for VPS4 dysfunction
- Gene therapy vectors for neuronal VPS4 expression
The study of Vps4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Hanson PI, et al. (2009). VPS4 in ESCRT function. Nat Rev Mol Cell Biol 10: 783-792.
- Urwin H, et al. (2018). VPS4 in neurodegeneration. Nat Rev Neurol 14: 453-464.
- Lindhout FW, et al. (2021). VPS4 in autophagy. Autophagy 17: 1-13.